Table: Towa Pharmaceutical - 6-MTH group results

TOWA PHARMACEUTICAL

11/11/2019 06:00

Nov 11 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               55.35               49.14           111.00    
                   (+12.6 pct)         (+9.9 pct)       (+5.6 pct)  
  Operating            9.22                5.92            14.50    
                   (+55.6 pct)         (+16.7 pct)      (-9.2 pct)  
  Recurring            9.74                8.37            14.60    
                   (+16.3 pct)         (+38.2 pct)      (-22.6 pct) 
  Net                  7.07                6.18            10.40    
                   (+14.4 pct)         (+43.5 pct)      (-22.8 pct) 
  EPS              143.60 yen          125.53 yen       211.34 yen  
  EPS Diluted      132.82 yen          116.11 yen                   
  Ann Div                              107.50 yen        44.00 yen  
  -Q2 div           22.00 yen           47.50 yen                   
  -Q4 div                               60.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T